Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation.

The mechanisms by which intraperitoneal injection of peripheral blood mono-nuclear cells (PBMCs) from Epstein-Barr virus (EBV)-seropositive donors into severe combined immunodeficient (SCID) mice gives rise to lymphomas (hu/SCID tumors) are far from clear. This study addressed whether chemokine receptors and their ligands could be implicated in this experimental model. CXCR4 was found to be highly expressed in hu/SCID tumors; surface expression of CXCR4 was prevalently limited to a tumor cell subset poorly expressing CD23, whereas the CXCR4 ligand, CXCL12, was predominantly expressed by the tumor subpopulation expressing CD23. In vitro inhibition of this autocrine/paracrine CXCL12/CXCR4 axis significantly inhibited lymphoma proliferation and survival. Furthermore, CXCL12 was expressed in cells recovered from the mouse peritoneal cavity early after PBMC transfer as well as by EBV-transformed B cells but not by resting or activated B lymphocytes; also, lymphoma development was associated with a dramatic increase in the levels of murine CXCL12 present in the peritoneal cavity. Finally, antagonizing the CXCL12/CXCR4 axis in vivo strongly counteracted lymphoma development. These studies demonstrate that CXCL12 expression may be associated with EBV infection and suggest that the CXCR4/CXCL12 axis may participate in the EBV-associated lymphomagenesis process in immunodeficient hosts.

[1]  T. Kipps,et al.  Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. , 1992, Cancer research.

[2]  J. Gordon,et al.  Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype. , 1996, International immunology.

[3]  A. Foussat,et al.  Production of stromal cell‐derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes , 2001, European journal of immunology.

[4]  L. Chieco‐Bianchi,et al.  Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development. , 1998, Journal of immunology.

[5]  Giovanni Martinelli,et al.  CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. , 2002, Cancer research.

[6]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[7]  K. Kato,et al.  Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. , 1990, Immunology.

[8]  A. Alberti,et al.  HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. , 1989, Journal of immunology.

[9]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[10]  S. Sallan,et al.  Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. , 2001, Blood.

[11]  D. Crawford,et al.  Essential role for T cells in human B‐cell lymphoproliferative disease development in severe combined immunodeficient mice , 2000, British journal of haematology.

[12]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[13]  L. Bonaldi,et al.  Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein–Barr virus reactivation , 2003, Leukemia.

[14]  D. Mosier,et al.  Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes , 1995, Journal of virology.

[15]  N. Cooper,et al.  Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Alon,et al.  The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. , 1999, The Journal of clinical investigation.

[17]  A. Otaka,et al.  T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer , 2003, FEBS letters.

[18]  S. Indraccolo,et al.  Alternatively spliced forms of Igα and Igβ prevent B cell receptor expression on the cell surface , 2002 .

[19]  L. Trentin,et al.  Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. , 2004, Blood.

[20]  A. Del Mistro,et al.  Lymphoproliferative disease in human peripheral blood mononuclear cell- injected SCID mice. I. T lymphocyte requirement for B cell tumor generation , 1992, The Journal of experimental medicine.

[21]  M. Ratajczak,et al.  The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells , 2001, Stem cells.

[22]  R. Custer,et al.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. , 1985, The American journal of pathology.

[23]  S. Fujita,et al.  Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1 , 2000, European journal of haematology.

[24]  F. Sánchez‐Madrid,et al.  The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes. , 1998, European journal of immunology.

[25]  S. Indraccolo,et al.  Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface. , 2002, European journal of immunology.

[26]  M. Janiak,et al.  Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. , 1994, Experimental hematology.

[27]  K. Takada,et al.  Human B Cells Immortalized with Epstein-Barr Virus Upregulate CCR6 and CCR10 and Downregulate CXCR4 and CXCR5 , 2002, Journal of Virology.

[28]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[29]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[30]  H. Tamamura.  [Development of selective antagonists against an HIV second receptor]. , 2001, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[31]  C. Bridts,et al.  Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. , 1994, Journal of immunological methods.

[32]  L. Chieco‐Bianchi,et al.  The hu-PBL-SCID mouse in human lymphocyte function and lymphomagenesis studies: achievements and caveats. , 1996, Seminars in Immunology.

[33]  J. Cyster,et al.  A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.

[34]  M. Le Bousse-Kerdilès,et al.  Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. , 2002, Blood.

[35]  G. Tosato,et al.  Interleukin-6 production in posttransplant lymphoproliferative disease. , 1993, The Journal of clinical investigation.

[36]  B. Moser,et al.  Activation-dependent modulation of B lymphocyte migration to chemokines. , 2000, International immunology.

[37]  F. Sánchez‐Madrid,et al.  The chemokine SDF‐1α triggers a chemotactic response and induces cell polarization in human B lymphocytes , 1998 .

[38]  A. Rosato,et al.  Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells , 2002, Gene Therapy.